{
    "SPADE_UN_13574": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13574",
            "Peptide Name": "Peptide 6",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GVLV",
            "Sequence Length": 4,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34502335]Virus:SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50≥20 μM);SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 μM);cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>4 µM);cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM);varicella-zoster virus (VZV) TK-VZV Strain 07–1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.34502335]Vero cell:CC50=77.4 ±0.7 µM.",
            "Binding Target": "Main protease",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Acylation",
            "C-terminal Modification": "Methyl amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C18H34N4O5",
            "Mass": 386.49,
            "PI": 5.53,
            "Net Charge": 0,
            "Hydrophobicity": 2.95,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antiviral activity against Influenza virus.",
            "Literature": [
                {
                    "Title": "Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2 Molecular Modelling, Synthesis and Bioactivity Evaluation.",
                    "Pubmed ID": "34502335",
                    "Reference": "Int J Mol Sci. 2021 Aug 30;22(17)9427.",
                    "Author": "Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34502335"
                }
            ],
            "Frequent Amino Acids": "VGL",
            "Absent Amino Acids": "ACDEFHIKMNOPQRSTUWY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 2,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00121",
                    "Similarity": 1.0,
                    "Sequence": "LSCDEGMLAVGGLGAVGGPWGAAVGVLVGAALYCF"
                },
                {
                    "SPADE_ID": "SPADE_N_01635",
                    "Similarity": 1.0,
                    "Sequence": "FLPFLAKILTGVL"
                },
                {
                    "SPADE_ID": "SPADE_N_02113",
                    "Similarity": 1.0,
                    "Sequence": "QEGCEWESRPCNRGCWLPRQWESVHMRFGVLVLWRAPQFEHFRECCNELRCEALRCMMRMRMEYWPRGLQDQQVYQRARDLEPRKHCGMSYPVECRMPR"
                }
            ]
        }
    }
}